- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Matching placebo to Sitagliptin/Metformin FDC
Total 232 results
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
AstraZenecaCompletedType 2 DiabetesUnited States, Hungary, Mexico, South Africa, Romania, Poland
-
Merck Sharp & Dohme LLCCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Kallyope Inc.Completed
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.CompletedType 2 Diabetes MellitusChina
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
AstraZenecaCompleted
-
Merck Sharp & Dohme LLCPfizerCompletedType 2 Diabetes Mellitus
-
AstraZenecaCompletedHeart Failure | Type 2 Diabetes MellitusUnited States, Thailand, Korea, Republic of, Russian Federation, Ukraine, Hungary, Bulgaria, Chile, Canada, Romania
-
AstraZenecaCompletedSaxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseDiabetes Mellitus, Type 2United States, Canada, Mexico, Puerto Rico, Taiwan, Australia
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
Bristol-Myers SquibbCompletedType 2 Diabetes MellitusSouth Africa, United States, Canada, Puerto Rico, Hungary, Germany, Czechia, Poland, Romania, United Kingdom
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, France, Switzerland, Germany, South Africa, Korea, Republic of, Puerto Rico, Canada, Taiwan, Spain, Poland, Slovakia, Thailand, Mexico, Turkey, Australia, Greece, Norway, Sweden, Peru, Romania, Argentina, United Kingdom
-
AstraZenecaCompletedType 2 Diabetes MellitusBrazil
-
AstraZenecaCompleted
-
Kallyope Inc.Completed
-
Merck Sharp & Dohme LLCTerminated
-
Janssen Sciences Ireland UCCompletedImmunodeficiency Virus Type 1, HumanUnited States, France, Poland, United Kingdom, Belgium, Germany, Spain, Canada, Russian Federation, Puerto Rico
-
AstraZenecaCompleted
-
Shanghai Pharmaceuticals Holding Co., LtdCompleted
-
AstraZenecaBristol-Myers SquibbCompletedDiabetes Mellitus, Type 2United States, Mexico, Canada, United Kingdom, India, Belgium, Taiwan
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus (T2DM)
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
AstraZenecaCompletedType 2 DiabetesKorea, Republic of, Mexico, South Africa, United States, Canada, Puerto Rico, Poland, Romania
-
Merck Sharp & Dohme LLCCompleted
-
AstraZenecaCompleted
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
AbbottCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Merck Sharp & Dohme LLCCompleted
-
AstraZenecaTerminatedType 2 Diabetes MellitusUnited States
-
CerecinCompleted
-
CerecinCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Merck Sharp & Dohme LLCCompleted
-
GlaxoSmithKlineCompletedPain, InflammatoryUnited Kingdom, Germany, Poland
-
Merck Sharp & Dohme LLCTerminated